DiJoseph, JF, K Khandke, MM Dougher, DY Evans, DC Armellino, PR Hamann, and NK Damle. 2009. “CMC-544 (inotuzumab ozogamicin): A CD22-Targeted Immunoconjugate of Calicheamicin”. Hematology Meeting Reports (formerly Haematologica Reports) 2 (5). https://doi.org/10.4081/hmr.v2i5.735.